In the intricate world of pharmaceutical development, the quality and availability of chemical intermediates directly influence the success of drug synthesis. 1,3-Dibromo-2-iodobenzene (CAS 19821-80-8) stands out as a significant building block, widely utilized as a pharmaceutical intermediate in the creation of complex organic molecules. For procurement specialists and R&D chemists, understanding its role and sourcing it effectively is key.

1,3-Dibromo-2-iodobenzene, also recognized by its synonym 2,6-Dibromoiodobenzene, is prized for its unique trifunctionalization, featuring two bromine atoms and one iodine atom on a benzene ring. This specific arrangement makes it a versatile precursor in various synthetic pathways. It allows for selective cross-coupling reactions, such as Suzuki, Stille, or Sonogashira couplings, which are fundamental techniques in modern pharmaceutical synthesis. These reactions enable the precise construction of carbon-carbon bonds, essential for building the complex architectures of many drug candidates.

As a crucial pharmaceutical intermediate, the purity of 1,3-Dibromo-2-iodobenzene is paramount. Impurities can lead to side reactions, reduced yields, and, most importantly, the potential contamination of the final Active Pharmaceutical Ingredient (API). Therefore, sourcing this compound from a manufacturer that guarantees high purity, typically 98% or above, is a non-negotiable aspect of the procurement process. Suppliers in China are a major source for this intermediate, and partnering with a reputable one ensures that these quality standards are met.

The ability to buy 1,3-Dibromo-2-iodobenzene in reliable quantities is also critical for drug manufacturing. From early-stage research requiring small amounts to commercial production demanding larger volumes, a consistent supply chain is vital. We understand these needs and, as a dedicated manufacturer and supplier, we ensure our production capabilities can meet diverse client requirements. This stability allows pharmaceutical companies to proceed with their development and manufacturing plans without interruption.

For any organization involved in pharmaceutical intermediate synthesis, securing a dependable source for 1,3-Dibromo-2-iodobenzene is a strategic advantage. We encourage you to consider us as your go-to supplier, offering high-purity material and consistent supply. Contact us today to request a quote and sample, and explore how we can support your critical drug development projects.